Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duska Dragun

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Trials|February 19, 2016
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trialClaudia Sommerer, Barbara Suwelack, Duska Dragun, et al.
Expert Opinion on Pharmacotherapy|May 28, 2004
Review of the immunosuppressant enteric-coated mycophenolate sodiumKlemens Budde, Petra Glander, Fritz Diekmann, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 21, 2012
Recovery of senescent endothelial cells from injuryKatarzyna Korybalska, Edyta Kawka, Angelika Kusch, et al.
Scientific Reports|January 14, 2021
High cut-off dialysis mitigates pro-calcific effects of plasma on vascular progenitor cellsTheres Schaub, Daniel Janke, Daniel Zickler, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|March 15, 2014
In arterial occlusive disease autoantibodies against ETAR and AT(1)R correlate with each other but are not associated with classical cardiovascular risk factorsChristian Albert, Marie von Schultzendorff, Delia Şalaru, et al.
Transplantation Reviews (Orlando, Fla.)|March 12, 2016
Immunological risk assessment: The key to individualized immunosuppression after kidney transplantationJohann Pratschke, Duska Dragun, Ingeborg A Hauser, et al.
Transplantation|August 7, 2016
Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral TransplantationUndine Ariane Gerlach, Nils Lachmann, Giuseppina Ranucci, et al.
Kidney International|June 14, 2013
The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammationRusan Catar, Janusz Witowski, Philine Wagner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 26, 2014
Human pregnancy and generation of anti-angiotensin receptor and anti-perlecan antibodiesGideon Hönger, Heloise Cardinal, Mélanie Dieudé, et al.
Mediators of Inflammation|February 14, 2014
Regulation of chemokine CCL5 synthesis in human peritoneal fibroblasts: a key role of IFN-γEdyta Kawka, Janusz Witowski, Nina Fouqet, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Trials|February 19, 2016
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trialClaudia Sommerer, Barbara Suwelack, Duska Dragun, et al.
Expert Opinion on Pharmacotherapy|May 28, 2004
Review of the immunosuppressant enteric-coated mycophenolate sodiumKlemens Budde, Petra Glander, Fritz Diekmann, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 21, 2012
Recovery of senescent endothelial cells from injuryKatarzyna Korybalska, Edyta Kawka, Angelika Kusch, et al.
Scientific Reports|January 14, 2021
High cut-off dialysis mitigates pro-calcific effects of plasma on vascular progenitor cellsTheres Schaub, Daniel Janke, Daniel Zickler, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|March 15, 2014
In arterial occlusive disease autoantibodies against ETAR and AT(1)R correlate with each other but are not associated with classical cardiovascular risk factorsChristian Albert, Marie von Schultzendorff, Delia Şalaru, et al.
Transplantation Reviews (Orlando, Fla.)|March 12, 2016
Immunological risk assessment: The key to individualized immunosuppression after kidney transplantationJohann Pratschke, Duska Dragun, Ingeborg A Hauser, et al.
Transplantation|August 7, 2016
Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral TransplantationUndine Ariane Gerlach, Nils Lachmann, Giuseppina Ranucci, et al.
Kidney International|June 14, 2013
The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammationRusan Catar, Janusz Witowski, Philine Wagner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 26, 2014
Human pregnancy and generation of anti-angiotensin receptor and anti-perlecan antibodiesGideon Hönger, Heloise Cardinal, Mélanie Dieudé, et al.
Mediators of Inflammation|February 14, 2014
Regulation of chemokine CCL5 synthesis in human peritoneal fibroblasts: a key role of IFN-γEdyta Kawka, Janusz Witowski, Nina Fouqet, et al.
Pageof 14